$Biora Therapeutics(BIOR.US)$Press Release: Biora Therapeutics Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules Dow Jones· 1 min ago
$Biora Therapeutics(BIOR.US)$performance targets achieved in single-ascending dose (SAD) cohorts of BT-600 clinical trial Results demonstrated targeted drug delivery and absorption in the colon, with 3-4 times lower drug levels in blood Remainder of BT-600 clinical trial progressing well and on schedule
The CFO of Biora Therapeutics, Eric d'Esparbes, expressed confidence in the company's progress towards optimizing its capital structure and developing its therapeutics programs. The recent transactions are seen as a strong indication of investors' continued confidence in Biora's programs.
Biora Therapeutics股票討論區
NEWS
Biora Therapeutics Announces Completion of Multiple-Ascending Dose (MAD) Cohorts for Clinical Trial of BT-600
News
Benzinga· 2 mins ago
Update
Dow Jones· 1 min ago
Cool! Like! Now need some data release dates!
Results demonstrated targeted drug delivery and absorption in the colon, with 3-4 times lower drug levels in blood
Remainder of BT-600 clinical trial progressing well and on schedule
暫無評論